Payer
Prime Minister Theresa May is expected to say that AI and data could save thousands of lives if used to improve diagnosis of cancer and other diseases, but experts warn that the ‘right infrastructure’ needs to be in place to underpin these developments.
In a new blog for BJ-HC, NHS Digital Director of Data Daniel Ray gives an update on the agency's data science strategy, revealing that a 'cognitive AI avatar' is in the works.
This morning Shanghai-based insurtech company CareVoice launched what it claims is the first AI voice-based virtual health assistant for insurers and employers in Greater China.
When it comes to dental health, companies seem to more and more see consumer technology and insurance as natural partners.
Wellness and patient engagement company Sharecare broke the news yesterday that it is teaming up with Blue Cross and Blue Shield of Minnesota to offer its personalized health platform to commercial customer groups starting in 2019.
Resembling recent disruption in the perception of an IT professional’s role, HIMSS Europe is establishing a new, first-of-its-kind community bringing together digital leaders that will drive the transformation of healthcare across the pan-European region going forward.
Addressing the three big themes at UK e-Health Week 2018 - Leadership, Global Lesson and Digital Advances, Adrian Byrne, CIO at University Hospital Southampton NHS Foundation Trust (UHS), shares the roadmap to UHS’ digital transformation journey, which has revolutionised its healthcare delivery.
Hello Heart — maker of an app-driven platform designed to help employees manage hypertension, heart rate, and cardiovascular health — has announced the release of a new service for diabetes management.
The race to see artificial intelligence ‘save’ the NHS needs to overcome the hurdle of GDPR. BJ-HC looks at the challenges ahead.
Today at HLTH: The Future of Healthcare Conference, San Francisco-based Vida Health announced an update to its digital health coaching platform for enterprises that is specifically designed to target comorbidities, as well as the launch of two separate offerings with a specific focus on diabetes and behavioral health treatment.